SI-BONE, Inc. Overview
Pro stress-test →SI-BONE is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone, with expertise in biomechanical design and anatomy-specific innovation. The company has built a technology platform with market-leading applications centered on spinopelvic anatomy. Since 2009, SI-BONE has supported physicians in performing nearly 150,000 procedures.
Strategic Profile
Pro stress-test →The company develops technologies centered on spinopelvic anatomy, including applications in minimally invasive SI joint fusion, adult spinal deformity, spinopelvic and sacropelvic fixation, and pelvic trauma. SI-BONE reported a 17% year-over-year increase in active U.S. physicians to over 1,650, underscoring growing confidence in the clinical efficacy and benefits of its procedural solutions for compromised bone.
Competitive Landscape
Pro stress-test →SI-BONE competes in the minimally invasive spinal fusion and orthopedic implant market against larger medtech companies and specialized orthopedic device makers. Key competitive considerations include Medtronic and Alphatec Holdings in spinal fusion, as well as other orthopedic device manufacturers offering sacroiliac joint or spinal deformity solutions. SI-BONE's differentiation centers on proprietary iFuse implant platform, strong clinical evidence base, and favorable reimbursement positioning.
Industry Context
SI-BONE, Inc. operates in Minimally invasive sacroiliac joint fusion devices.
Key facts
Founded: 2009 · Headquarters: San Jose, US · Revenue: $200.8M–$200.9M (FY2025); Guidance: $230M–$233M (FY2026) · Market cap: $579M